Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic botulinum toxin A injection for prevention and treatment of esophageal stricture after ESD
ChiCTR-TRC-12003188Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in Esophageal stricture (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Symptom scores of dysphagia, Esophageal diameter and 4 more. Started Jun 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Esophageal stricture
Beyond the preview
Go deeper on ChiCTR-TRC-12003188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003188.